Clark joins GSK-backed Genocea Biosciences

Genocea Biosciences, a US-based vaccine development company backed by GlaxoSmithkline’s (GSK) corporate venturing division, has hired Chip Clark as chief business officer.

Clark will focus on commercial, business development and venture capital financing at Genocea. He previously held a similar role at Vanda Pharmaceuticals, which completed a licensing deal with pharmaceuticals company Novartis worth $200m upfront plus $265m in additional milestones, and raised more than $220m in multiple public and private financings, including from corporate venturing unit MedImmune Ventures,…